Global veterinary tuberculosis vaccine market is estimated to be valued at US$ 50.89 Mn in 2022 and is expected to exhibit a CAGR of 3.2% over the forecast period (2022-2030).
Figure 1: Global Veterinary Tuberculosis Vaccine Market Share (%) Analysis, By Product Type, 2022
Increasing government initiative for veterinary tuberculosis vaccine is expected propel the global veterinary tuberculosis vaccine market growth over the forecast period.
Increasing government initiative for veterinary tuberculosis vaccine is expected propel the global veterinary tuberculosis vaccine market growth over the forecast period. For instance, on July 22, 2020, the Department for Environment, Food & Rural Affairs and Animal and Plant Health Agency, U.K, had given permission to scientists from U.K. government research organization to conduct field trial for bovine tuberculosis (bTB) TB cattle vaccination. These field trials would be conducted over the next four years from 2021 till 2024 on behalf of Defra, the Welsh Government and the Scottish Government, following of ground-breaking research into bovine TB vaccines and diagnostic tests.
Increasing research and development for tuberculosis vaccine is expected to drive the global veterinary tuberculosis vaccine market growth over the forecast period.
Increasing research and development for tuberculosis vaccine is expected to drive the global veterinary tuberculosis vaccine market growth over the forecast period. For instance, on November 28, 2019, an article was published by the University of Surrey about the research for new vaccine developed for treating bovine tuberculosis (bovine TB) in form of a novel vaccine and complementary skin test to protect cattle. The scientific study has been published for novel vaccine and complementary skin test to protect cattle. The protective efficiency of the new strain was tested in guinea pigs.
Global Veterinary Tuberculosis Vaccine Market- Impact of the Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization declared it a public health emergency on January 30, 2020.
The COVID-19 can affect the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others are facing problems with regard to the transportation of drugs from one place to another.
The current pandemic of COVID-19 has set off an urgent search for an effective vaccine. This search may well benefit from the experiences of the animal health profession in the development and use of coronavirus vaccines in domestic animal species. According to an article published on July 14, 2020 by the National Center for Biotechnology Information (NCBI) stated about new developed vaccine for animal species, where two types of vaccine have been developed against alphacoronaviru (CCoV) such as inactivated and live-attenuated vaccination for dogs with an inactivated CCoV vaccine reduced the level of viral shedding in the feces and was effective following experimental challenge in dogs. Thus, 15% of vaccinated dogs developed mild symptoms while 80% of unvaccinated dogs developed disease symptoms and 60% eventually developed severe symptoms.
Veterinary Tuberculosis Vaccine Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients